These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9922114)

  • 21. Inhibin and p27 interact to regulate gonadal tumorigenesis.
    Cipriano SC; Chen L; Burns KH; Koff A; Matzuk MM
    Mol Endocrinol; 2001 Jun; 15(6):985-96. PubMed ID: 11376116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of androgens in testicular tumor development in inhibin-deficient mice.
    Shou W; Woodruff TK; Matzuk MM
    Endocrinology; 1997 Nov; 138(11):5000-5. PubMed ID: 9348231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit.
    McMullen ML; Cho BN; Yates CJ; Mayo KE
    Endocrinology; 2001 Nov; 142(11):5005-14. PubMed ID: 11606469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
    Rahman NA; Kiiveri S; Rivero-Müller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I
    Mol Endocrinol; 2004 Oct; 18(10):2553-69. PubMed ID: 15256532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.
    Kumar TR; Wang Y; Matzuk MM
    Endocrinology; 1996 Oct; 137(10):4210-6. PubMed ID: 8828479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sexually dimorphic roles of steroid hormone receptor signaling in gonadal tumorigenesis.
    Burns KH; Agno JE; Chen L; Haupt B; Ogbonna SC; Korach KS; Matzuk MM
    Mol Endocrinol; 2003 Oct; 17(10):2039-52. PubMed ID: 12855748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.
    Rajanahally S; Agno JE; Nalam RL; Weinstein MB; Loveland KL; Matzuk MM; Li Q
    Reprod Biol Endocrinol; 2010 Jun; 8():69. PubMed ID: 20565978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
    Marino FE; Risbridger G; Gold E
    Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indirect Sertoli cell-mediated ablation of germ cells in mice expressing the inhibin-alpha promoter/herpes simplex virus thymidine kinase transgene.
    Ahtiainen M; Toppari J; Poutanen M; Huhtaniemi I
    Biol Reprod; 2004 Nov; 71(5):1545-50. PubMed ID: 15240419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMAD3 regulates gonadal tumorigenesis.
    Li Q; Graff JM; O'Connor AE; Loveland KL; Matzuk MM
    Mol Endocrinol; 2007 Oct; 21(10):2472-86. PubMed ID: 17595316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteinizing hormone promotes gonadal tumorigenesis in inhibin-deficient mice.
    Nagaraja AK; Agno JE; Kumar TR; Matzuk MM
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):19-28. PubMed ID: 18657590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis.
    Matzuk MM; Finegold MJ; Mishina Y; Bradley A; Behringer RR
    Mol Endocrinol; 1995 Oct; 9(10):1337-45. PubMed ID: 8544842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulable expression of inhibin A in wild-type and inhibin alpha null mice.
    Pierson TM; Wang Y; DeMayo FJ; Matzuk MM; Tsai SY; Omalley BW
    Mol Endocrinol; 2000 Jul; 14(7):1075-85. PubMed ID: 10894156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1.
    Garson K; Macdonald E; Dubé M; Bao R; Hamilton TC; Vanderhyden BC
    J Soc Gynecol Investig; 2003 May; 10(4):244-50. PubMed ID: 12759154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive deficiencies in transgenic mice expressing the rat inhibin alpha-subunit gene.
    Cho BN; McMullen ML; Pei L; Yates CJ; Mayo KE
    Endocrinology; 2001 Nov; 142(11):4994-5004. PubMed ID: 11606468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different 5'-flanking regions of the inhibin-alpha gene target transgenes to the gonad and adrenal in an age-dependent manner in transgenic mice.
    Hsu SY; Lai RJ; Nanuel D; Hsueh AJ
    Endocrinology; 1995 Dec; 136(12):5577-86. PubMed ID: 7588311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced ablation of gonadotropins in transgenic mice expressing herpes simplex virus thymidine kinase under the FSH beta-subunit promoter.
    Markkula M; Kananen K; Paukku T; Männistö A; Loune E; Fröjdman K; Pelliniemi LJ; Huhtaniemi I
    Mol Cell Endocrinol; 1995 Feb; 108(1-2):1-9. PubMed ID: 7758821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions.
    Allan CM; Haywood M; Swaraj S; Spaliviero J; Koch A; Jimenez M; Poutanen M; Levallet J; Huhtaniemi I; Illingworth P; Handelsman DJ
    Endocrinology; 2001 Jun; 142(6):2213-20. PubMed ID: 11356665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.